Inventor · disambiguated record
Dustin James Mergott
Also filed as: MERGOTT DUSTIN JAMES
12 granted patents·5 pending applications·105 citations·filing 2009–2021
89Inventor score
Top patents by PatentIndex Score
17 records- 0194US7648983B2BACE inhibitorsLILLY CO ELI·Filed 2009·Granted Jan 19, 2010·37 cites·13 claims
- 0291US9999624B2Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitorLILLY CO ELI·Filed 2015·Granted Jun 19, 2018·8 cites·15 claims
- 0391US8841293B1Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2014·Granted Sep 23, 2014·14 cites·5 claims
- 0490US8278441B2BACE inhibitorsMERGOTT DUSTIN JAMES·Filed 2010·Granted Oct 2, 2012·38 cites·1 claims
- 0581US8629270B2Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2013·Granted Jan 14, 2014·4 cites·2 claims
- 0679US8987254B2Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2014·Granted Mar 24, 2015·3 cites·6 claims
- 0768US9328124B2BACE inhibitorsLILLY CO ELI·Filed 2013·Granted May 3, 2016·1 cites·11 claims
- 0864US9029367B2BACE inhibitorsLILLY CO ELI·Filed 2014·Granted May 12, 2015·0 cites·15 claims
- 0961US8889856B2Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2014·Granted Nov 18, 2014·0 cites·8 claims
- 1060US8772282B2Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2013·Granted Jul 8, 2014·0 cites·12 claims
- 1156US2023338349A1Low dose regimen and formulation of a 5-methyl-1,2,4-oxadiazol-3-yl compoundLILLY CO ELI·Filed 2021·Application pending·0 cites
- 1255US10399995B21,4-Oxazines useful as selective BACE1 inhibitorsLILLY CO ELI·Filed 2017·Granted Sep 3, 2019·0 cites·10 claims
- 1354US9169271B2BACE inhibitorsLILLY CO ELI·Filed 2015·Granted Oct 27, 2015·0 cites·14 claims
- 1446US2015157641A1Tetrahydropyrrolothiazine compoundsLILLY CO ELI·Filed 2015·Application pending·0 cites
- 1541US2019231791A1Combination TherapyLILLY CO ELI·Filed 2017·Application pending·0 cites
- 1640US2019365774A1Combination therapy of bace-1 inhibitor and anti-n3pglu abeta antibodyLILLY CO ELI·Filed 2017·Application pending·0 cites
- 1739US2019046536A1Combination TherapyLILLY CO ELI·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →